Page 3 - Best Testicular cancer doctors: TOP 102 doctors

Dr. Dror Levin specializes in pediatric oncology, with a focus on bone cancer (sarcoma) in children at Sourasky Medical Center.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israel Society of Pediatric Hematology and Oncology (ISPHO)
• Trained in bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

Prof. Haim Matskin is a leading authority in onco-urology, specializing in testicular cancer treatment at Sourasky Medical Center.

• Heads the Urology Department at Sourasky Medical Center
• Expert in brachytherapy and cryotherapy for malignant tumors
• Member of the Medical Association of Israel and international urology associations

Internationally recognized oncologist with over 22 years of experience of experience leading clinical divisions and research in targeted cancer therapies. He practices personalized medicine at Wiener Privatklinik.

• Expert in solid tumor oncology, especially breast and gynecologic cancers
• Associate Professor at the Medical University of Vienna, contributing to new treatment strategies
• Deputy Head of Clinical Division of Oncology, advancing translational cancer research
• Specializes in biomarker development and individualized systemic therapy

Prof. Jack Baniel leads urology at Rabin Medical Center, specializing in nerve-sparing cancer surgeries with robotic precision. He founded the oncourology department at Beilinson Hospital.

• Performs bladder reconstruction and robotic prostatectomy
• Published 100+ scientific articles on uro-oncology
• Member of European and American urology associations
• Involved in global clinical research collaborations

Dr. Avi Beri specializes in comprehensive urological treatments at Sourasky Medical Center, including prostatectomy and TURP.

• Expert in kidney stones treatment and vasectomy
• Provides urology consultations for various conditions
• Focuses on helping patients achieve a healthy life

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience at multiple oncology clinics in Turkey
• Promoted to Associate Professor in 2016
• Studied at Selcuk University Faculty of Medicine

Associate Professor Dr. Yusuf Acikgoz brings international oncology expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in medical oncology with a focus on testicular cancer
• Participated in Phase III clinical trials like CheckMate-649 and Fortitude-101
• Certified in Good Clinical Practice and Human Subjects Protection
• Member of American Society of Clinical Oncology (ASCO)

Professor Cemil Bilir brings over 21 years of experience of specialized experience in medical oncology, with training at top institutions like Cleveland Clinic and Northeastern University.

• Specializes in treating testicular cancer using the latest protocols
• Member of ASCO and ESMO – stays current with global standards
• Teaches future oncologists as a professor at Sakarya University
• Completed fellowship at Northeastern University's Center for Pharmaceutical Biotechnology

Specializing in medical oncology, Dr. Alemdar brings focused expertise in testicular cancer at Medical Park Antalya Hospital Complex.

• Trained at Akdeniz University, one of Turkey's leading medical schools
• Over 20 years of experience of dedicated experience in medical oncology
• Handles both diagnosis and treatment planning for testicular cancer
• Works at a JCI-accredited hospital with advanced oncology facilities

Associate Professor Nail Paksoy specializes in testicular cancer treatment, with a medical oncology fellowship from Istanbul University and ESMO Board Certification.

• Participated in 8 international clinical trials for cancer treatments
• Published multiple studies on metastatic cancers in peer-reviewed journals
• Member of the European Society for Medical Oncology (ESMO)

Dr. Ozden brings over 27 years of experience of experience in internal medicine and medical oncology, specializing in testicular cancer at VM Medical Park Pendik Hospital.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Practiced at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital
• Graduated from Istanbul University, Cerrahpaşa Faculty of Medicine

49 years of experience specializing in virotherapy – Dr. Jaunalksne leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital.

• Graduate of Riga Medical Institute with an internship in Internal Medicine
• Head of Clinical Immunology Center – oversees cutting-edge immunology treatments
• Focuses on innovative virotherapy approaches for cancer treatment

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.